Catheter Precision, Inc.

VTAK · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap$27,969$421,802$1,157,149$1,496,820
- Cash$2,873$3,565$15,859$15,045
+ Debt$1,788$372$124$2,264
Enterprise Value$26,884$418,609$1,141,415$1,484,039
Revenue$420$442$14$22
% Growth-5%3,057.1%-36.4%
Gross Profit$378$412-$147-$1,538
% Margin90%93.2%-1,050%-6,990.9%
EBITDA-$11,302-$15,110-$22,368-$25,847
% Margin-2,691%-3,418.6%-159,771.4%-117,486.4%
Net Income-$16,643-$70,572-$26,865-$25,070
% Margin-3,962.6%-15,966.5%-191,892.9%-113,954.5%
EPS Diluted-6.68-12.99-25.98-248.22
% Growth48.6%50%89.5%
Operating Cash Flow-$9,271-$20,619-$22,568-$27,625
Capital Expenditures-$67-$76-$17-$265
Free Cash Flow-$9,338-$20,695-$22,585-$27,890
Catheter Precision, Inc. (VTAK) Financial Statements & Key Stats | AlphaPilot